Humacyte, Inc.

Description

Humacyte’s mission is to become the leading company in researching and developing novel, off-the-shelf extracellular matrix tissue products that, once approved, can significantly improve treatment outcomes in patients with a variety of disease conditions. Humacyte is a privately-held company that was co-founded in 2005 by Laura Niklason, MD. PhD., a world leader in tissue engineering, and currently Professor of Biomedical Engineering and Anesthesiology at Yale University. Niklason co-founded Humacyte along with Drs. Shannon Dahl and Juliana Blum. Humacyte’s research platforms and core technologies are based on the research conducted by Drs. Niklason and Dahl at Duke University, and by Dr. Niklason at the Massachusetts Institute of Technology in the laboratory of Dr. Robert Langer. Humacyte’s other senior management, advisors and board of directors have extensive, proven experience in product development, clinical trials, regulatory affairs, business and commercial development, finance and intellectual property management.

Humacyte, a privately held company, is primarily focused on developing products for vascular disease and for therapeutic filling and soft tissue repair. The company uses its innovative and proprietary platform technology to engineer human, extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues.

Humacyte, a privately held company, is primarily focused on developing investigational products for vascular disease and for replacement of anatomical conduits. The company uses its innovative and proprietary platform technology to engineer human, extracellular matrix-based investigational tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues. Incorporated in late 2004, Humacyte licensed technology from MIT and Duke University. Since then, Humacyte has made considerable progress in the development and pre-clinical testing of our investigational biologic vascular grafts.

Fact sheet

Products & services

Similar companies nearby